Ray Dalio's JNJ Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 1.72 M shares of Johnson & Johnson (JNJ) worth $318.14 M, representing 1.25% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 49 quarters.
Based on 13F filings since 2013, Ray Dalio has maintained a long-term strategic position in JNJ, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2025, adding 1.99 M shares. Largest reduction occurred in Q3 2024, reducing 1.73 M shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Johnson & Johnson (JNJ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Johnson & Johnson (JNJ) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2013 | +27,293 | New Buy | 27,293 | $86.69 |
| Q4 2013 | +85,900 | Add 314.73% | 113,193 | $91.59 |
| Q1 2014 | +149,800 | Add 132.34% | 262,993 | $98.23 |
| Q2 2014 | -197,100 | Reduce 74.94% | 65,893 | $104.62 |
| Q3 2014 | +18,300 | Add 27.77% | 84,193 | $106.59 |
| Q4 2014 | -19,900 | Reduce 23.64% | 64,293 | $104.57 |
| Q1 2015 | +203,800 | Add 316.99% | 268,093 | $100.60 |
| Q2 2015 | -73,100 | Reduce 27.27% | 194,993 | $97.46 |
| Q3 2015 | -27,400 | Reduce 14.05% | 167,593 | $93.35 |
| Q4 2015 | -57,900 | Reduce 34.55% | 109,693 | $102.72 |
| Q1 2016 | -109,693 | Sold Out | 109,693 | $0.00 |
| Q2 2016 | +129,700 | New Buy | 129,700 | $121.30 |
| Q3 2016 | -85,300 | Reduce 65.77% | 44,400 | $118.13 |
| Q4 2016 | -44,400 | Sold Out | 44,400 | $0.00 |
| Q2 2018 | +109,950 | New Buy | 109,950 | $121.34 |
| Q3 2018 | -32,135 | Reduce 29.23% | 77,815 | $138.17 |
| Q4 2018 | -77,815 | Sold Out | 77,815 | $0.00 |
| Q1 2020 | +8,215 | New Buy | 8,215 | $131.10 |
| Q2 2020 | -8,215 | Sold Out | 8,215 | $0.00 |
| Q3 2020 | +665,402 | New Buy | 665,402 | $148.88 |
| Q4 2020 | +804,367 | Add 120.88% | 1.47 M | $157.38 |
| Q1 2021 | +240,126 | Add 16.34% | 1.71 M | $164.35 |
| Q2 2021 | +1.11 M | Add 65.10% | 2.82 M | $164.74 |
| Q3 2021 | -69,070 | Reduce 2.45% | 2.75 M | $161.50 |
| Q4 2021 | +343,706 | Add 12.48% | 3.1 M | $171.07 |
| Q1 2022 | +1.25 M | Add 40.26% | 4.35 M | $177.23 |
| Q2 2022 | -12,369 | Reduce 0.28% | 4.33 M | $177.51 |
| Q3 2022 | +379,880 | Add 8.77% | 4.71 M | $163.36 |
| Q4 2022 | -1.14 M | Reduce 24.29% | 3.57 M | $176.65 |
| Q1 2023 | +19,563 | Add 0.55% | 3.59 M | $155.00 |
| Q2 2023 | -406,023 | Reduce 11.32% | 3.18 M | $165.52 |
| Q3 2023 | -457,073 | Reduce 14.37% | 2.72 M | $155.75 |
| Q4 2023 | +50,332 | Add 1.85% | 2.77 M | $156.74 |
| Q1 2024 | +68,546 | Add 2.47% | 2.84 M | $158.19 |
| Q2 2024 | +361,072 | Add 12.70% | 3.2 M | $146.16 |
| Q3 2024 | -1.73 M | Reduce 54.12% | 1.47 M | $162.06 |
| Q4 2024 | -932,184 | Reduce 63.41% | 537,937 | $144.62 |
| Q1 2025 | -240,649 | Reduce 44.74% | 297,288 | $165.84 |
| Q2 2025 | +1.99 M | Add 667.79% | 2.28 M | $152.75 |
| Q3 2025 | -566,762 | Reduce 24.83% | 1.72 M | $185.42 |
Ray Dalio's Johnson & Johnson Investment FAQs
Ray Dalio first purchased Johnson & Johnson (JNJ) in Q3 2013, acquiring 27,293 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Johnson & Johnson (JNJ) for 49 quarters since Q3 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to Johnson & Johnson (JNJ) was in Q2 2025, adding 2,282,539 shares worth $348.66 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 1,715,777 shares of Johnson & Johnson (JNJ), valued at approximately $318.14 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Johnson & Johnson (JNJ) represents approximately 1.25% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in Johnson & Johnson (JNJ) was 4,712,513 shares, as reported at the end of Q3 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.